N
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K817.2 KBNeos Therapeutics, Inc.Mar 22, 6:11 AM ET·0001213900-21-016770
- SC 13G/A88.2 KBNeos Therapeutics, Inc.Feb 16, 8:52 AM ET·0001178913-21-000592
- SC 13G/A58.3 KBNeos Therapeutics, Inc.Feb 12, 5:07 PM ET·0000935836-21-000125
- SC 13G/A54.4 KBNeos Therapeutics, Inc.Feb 12, 6:47 AM ET·0001104659-21-021138
- SC 13G/A23.8 KBNeos Therapeutics, Inc.Feb 11, 8:33 PM ET·0000769993-21-000107
- 8-K723.1 KBNeos Therapeutics, Inc.Feb 8, 4:14 PM ET·0001558370-21-000807
- 8-K6.3 MBNeos Therapeutics, Inc.Jan 11, 8:45 AM ET·0001104659-21-002748
- 8-K169.0 KBNeos Therapeutics, Inc.Dec 30, 4:07 PM ET·0001558370-20-014576
- 8-K10.2 MBNeos Therapeutics, Inc.Dec 11, 6:01 AM ET·0001104659-20-134415
- 8-K254.7 KBNeos Therapeutics, Inc.Dec 10, 8:21 AM ET·0001104659-20-133959
Insiders
10- Edick Paul RDirector
- Eisenstadt Richard IChief Financial Officer
- Engelking DorothyVP, Regulatory Affairs
- Fong BryantDirector
- Garg Vipin KDirector, Chief Executive Officer
- Hecht BethDirector
- HELLER ALAN LDirector
- Limongelli John MSVP & General Counsel
- Martens JuergenChief Tech/Operations Officer
- McDonnell Thomas PChief Commercial Officer
Tickers
No tickers on record
Addresses
business
2940 N. HIGHWAY 360 SUITE 400
GRAND PRAIRIE, TX, 75050
mailing
2940 N. HIGHWAY 360 SUITE 400
GRAND PRAIRIE, TX, 75050